49 results found.

Atherosclerosis of Autologous Vein Coronary Artery Bypass Graft(s Clinical Trial using eSVS Mesh treated saphenous vein graft; Control saphenous vein graft

Kips Bay Medical, Inc. - Recruiting 21 years to 80 years.
- A Multi-center, International Study of External Saphenous Vein Support Using eSVSr Mesh in CABG Surgery: The eMESH I Study.
eSVS Mesh treated saphenous vein graft; Control saphenous vein graft

Coronary Artery Disease, or Atherosclerosis Clinical Trial

InfraReDx - Recruiting N/A or older.
- The Lipid-Rich Plaque (LRP) Study.

Intracranial Atherosclerosis Clinical Trial using Wingspan Stent System

Stryker Neurovascular - Recruiting N/A or older.
- WEAVET Trial: Wingspan StEnt System Post MArket SurVEillance Study.
Wingspan Stent System

Atherosclerosis, or Hypercholesterolemia Clinical Trial using LDL. Cholesterol (Statin Drugs); HMG-CoA Reductase Inhibitors

National Institutes of Health Clinical Center (CC) - Recruiting 55 years or older.
- Randomized Trial of Imaging Versus Risk Factor Based Therapy for Plaque Regression.
LDL. Cholesterol (Statin Drugs); HMG-CoA Reductase Inhibitors

Congenital Heart Disease, Atherosclerosis, Myocardial Ischemia, M Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Suburban/NHLBI Cardiovascular Disease Screening Protocol.

Chronic Granulomatous Disease (CGD), Atherosclerosis, Immune Defi Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System.

Carotid Stenosis, Atherosclerosis, Stroke, Transient-ischaemic At Clinical Trial using Revacept; Placebo

AdvanceCor GmbH - Recruiting 18 years or older.
- Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Phase II, Multicentre; Randomised, Dose-finding, Double-blind and Placebo Controlled Superiority Study With Parallel Groups.
Revacept; Placebo

Atherosclerosis, or Coronary Artery Disease Clinical Trial

University Hospital Inselspital, Berne - Recruiting 18 years or older.
- Innate Human Collateral Supply to Different Vascular Regions.

Metabolic Syndrome Clinical Trial using Niacin; Saturated meal; Monounsaturated meal; Polyunsaturated meal

National Research Council, Spain - Recruiting 18 years or older.
- OLIVE OIL ON NAMPT AND ITS RELATION WITH POSTPRANDIAL INFLAMMATION AND ATHEROSCLEROSIS IN THE SETTING OF METABOLIC SYNDROME. The OLNAMS Project.
Niacin; Saturated meal; Monounsaturated meal; Polyunsaturated meal

Hypertension, or Atherosclerosis Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 50 years to 90 years.
- Age-Associated Changes in Regional Adiposity and Novel Cardiovascular Risk Factors.

Coronary Artery Occlusive Disease Clinical Trial using Pravastatin 40mg; Rosuvastatin

Yonsei University - Recruiting 20 years to 80 years.
- .
Pravastatin 40mg; Rosuvastatin

Peripheral Artery Disease, Claudication, Atherosclerosis, or Arte Clinical Trial using Ranger DCB; uncoated PTA balloon

Hemoteq AG - Recruiting 18 years or older.
- Prospective, Randomized, Multicentre Clinical Study of the Hemoteq RangerT Paclitaxel-Coated PTA Balloon Catheter (Ranger DCB) in Comparison to Uncoated PTA Balloons in Femoropopliteal Lesions.
Ranger DCB; uncoated PTA balloon

Menopause, Aging, or Vascular Health Clinical Trial using KUVAN; Placebo; Cetrotide; Climara; Placebo transdermal patch

University of Colorado, Denver - Recruiting 18 years to 70 years.
- Biological Mechanisms of Vascular Dysfunction With Age and Estrogen Deficiency.
KUVAN; Placebo; Cetrotide; Climara; Placebo transdermal patch

Atherosclerosis Clinical Trial

University of California, San Francisco - Recruiting 18 years to 65 years.
- Immunologic and Inflammatory Factors and Cardiovascular Risk in Patients With HIV Infection or Autoimmune Diseases.

Atherosclerosis Clinical Trial

Mount Sinai School of Medicine - Recruiting 20 years or older.
- In Vivo Molecular Imaging (MRI) of Atherothrombotic Lesions.

Abetalipoproteinemia, Atherosclerosis, Healthy, or Inborn Errors Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Lipoprotein Metabolism in Normal Volunteers and Hyperlipoproteinemic Patients.

Coronary Atherosclerosis, or Endothelial Dysfunction Clinical Trial using Blood sampling from the Coronary Sinus and Aorta; Intravascular Ultrasound of the coronary artery.

Mayo Clinic - Recruiting 18 years to 85 years.
- Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans.
Blood sampling from the Coronary Sinus and Aorta; Intravascular Ultrasound of the coronary artery.

Endothelial Dysfunction Clinical Trial using darapladib; placebo

Mayo Clinic - Recruiting 18 years to 85 years.
- Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III.
darapladib; placebo

Metabolic Disease, Cardiovascular Disease, or Inflammation Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Human Translational Studies of Inflammation and Cardiometabolic Diseases: The Psoriasis, Atherosclerosis and Cardiometabolic Disease (PACI) Initiative.

Dyslipidemia Clinical Trial using PRC-4016

Pronova BioPharma - Recruiting 18 years to 79 years.
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled 12-Week Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of PRC-4016 600 mg Once Daily Versus Placebo in Statin-Stable Subjects With Mixed Dyslipidemia.
PRC-4016

Metabolic Syndrome, Cardiovascular Disease, Atherosclerosis, or O Clinical Trial using My Everyday Health

Baptist Health South Florida - Recruiting 18 years or older.
- Baptist Employee Healthy Heart Study (BEHHS) - A Novel Web-based Approach to Reduce Cardiovascular Disease Risk in a Diverse Employee Population With Metabolic Syndrome Via Diet and Lifestyle Change.
My Everyday Health

Peripheral Arterial Disease Clinical Trial using Angioplasty with Zilver PTX; Best medical treatment; Zilver PTX

Rigshospitalet, Denmark - Recruiting 18 years or older.
- Paclitaxel Eluting Stent or Exercise for Thigh Atherosclerosis (PESETA).
Angioplasty with Zilver PTX; Best medical treatment; Zilver PTX

Atherosclerosis, or Plaque, Atherosclerotic Clinical Trial

David Grant U.S. Air Force Medical Center - Recruiting 35 years or older.
- Assessment of Coronary Artery Calcium in Active Duty Enlisted Military Members With 10 or More Years of Service.

Carotid Artery Stenosis, Atherosclerosis, or Stroke Clinical Trial using Carotid Endarterectomy; atorvastatin, aspirin, losartan, amlodipine

Russian Cardiology Research and Production Center - Recruiting 40 years to 80 years.
- Carotid Endarterectomy Versus Optimal Medical Treatment of Asymptomatic High Grade Carotid Artery Stenosis.
Carotid Endarterectomy; atorvastatin, aspirin, losartan, amlodipine

Atherosclerosis Clinical Trial

Piedmont Healthcare - Recruiting 18 years or older.
- Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program.

Atherosclerosis Clinical Trial using blood sample

Centre Hospitalier Universitaire de Saint Etienne - Recruiting 18 years or older.
- Search a Correlation Between Lipoprotein(a) Rate and TFPI(Tissue Factor Pathway Inhibitor)Activity in Obese Patients With Chest Pain Like Angina.
blood sample

Hypothyroidism, Thyroid Diseases, or Endocrine System Diseases Clinical Trial using L-thyroxine

Shandong Provincial Hospital - Recruiting 40 years to 75 years.
- Effects of Long-term L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Patients With Hypothyroid.
L-thyroxine

Atherosclerosis Clinical Trial using Crossover of R-alpha lipoic acid and placebo

Oregon State University - Recruiting 50 years to 70 years.
- The Role of R-alpha Lipoic Acid in Treatment of Atherosclerotic Vascular Disease.
Crossover of R-alpha lipoic acid and placebo

Atherosclerosis Clinical Trial using R-alpha lipoic acid; Placebo

Oregon State University - Recruiting 18 years to 60 years.
- The Role of R-alpha Lipoic Acid in Prevention of Atherosclerotic Vascular Disease.
R-alpha lipoic acid; Placebo

Coronary Artery Disease, or Coronary Stenosis Clinical Trial

Maastricht University Medical Center - Recruiting 18 years or older.
- Maastricht Biomarker CT Study. Relation Between Cardiovascular Biomarkers and Coronary Atherosclerosis in Patients Undergoing Multi Detector Cardiac Computed Tomography..

Metabolic Syndrome Clinical Trial using aged garlic extract; placebo

Los Angeles Biomedical Research Institute - Recruiting 40 years to 65 years.
- Effect of Aged Garlic Extract on Atherosclerosis.
aged garlic extract; placebo

Atherosclerosis, or Inflammation Clinical Trial using Atorvastatin; Lifestyle counseling

National Defense Medical College, Japan - Recruiting 18 years to 80 years.
- Effect of Atorvastatin on Inflammatory Atherosclerotic Plaques Assessed by FDG-PET Imaging.
Atorvastatin; Lifestyle counseling

Coronary Artery Disease Clinical Trial

University of Roma La Sapienza - Recruiting 18 years or older.
- PROgenitor Cells Role in Restenosis and Progression of Coronary ATherosclerosis After Percutaneous Coronary Intervention (PROCREATION) Study.

Non-diabetic Chronic Kidney Disease, or Atherosclerosis Clinical Trial

Kocaeli Derince Education and Research Hospital - Recruiting 18 years to 75 years.
- The Relationship Between Serum Omentin-1 and IL-6 and Carotid Atherosclerosis In Non-Diabetic Chronic Kidney Disease.

Morbid Obesity, Atherosclerosis, or Systemic Inflammation Clinical Trial using Placebo; Alpha-linolenic acid/ALA; Alpha linolenic acid/ALA

University of Sao Paulo - Recruiting 18 years to 65 years.
- Inflammatory Indicators and Arterial Stiffness in Patients With Severe Obesity. Response to Supplementation of Alpha Linolenic Acid.
Placebo; Alpha-linolenic acid/ALA; Alpha linolenic acid/ALA

Abdominal Aortic Aneurysm, Carotid Atherosclerosis, or Critical L Clinical Trial using Remote preconditioning

Mid Western Regional Hospital, Ireland - Recruiting 18 years or older.
- Preconditioning Shields Against Vascular Events in Surgery. A Multi-Centre Trial of Preconditioning Against Adverse Events in Major Vascular Surgery.
Remote preconditioning

Chronic Obstructive Pulmonary Disease and Allied Conditions Clinical Trial using Roflumilast; Placebo

LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology - Recruiting 40 years to 80 years.
- Effects of ROFLUMILAST on Markers of Subclinical Atherosclerosis In Stable COPD; the ELASTIC-trial.
Roflumilast; Placebo

Brain Ischemia Clinical Trial using Aggressive BP lowering; modest blood pressure lowering

Asan Medical Center - Recruiting 40 years or older.
- Multicenter Clinical Trial for Development of Guidelines of Adequate Blood Pressure Lowering in the Subacute Ischemic Stroke Patients Due to Intracranial Atherosclerosis.
Aggressive BP lowering; modest blood pressure lowering

Metabolic Syndrome, Atherosclerosis Clinical Trial

Korea University - Recruiting 20 years to 80 years.
- .

Renal Transplant, Atherosclerosis, or Arterial Stiffness Clinical Trial using no intervention

Universitaire Ziekenhuizen Leuven - Recruiting 18 years to 90 years.
- Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients.
no intervention

Atherosclerosis Clinical Trial using Cross section study

Korea University - Recruiting 20 years to 80 years.
- Comparison of 18F-fluorodeoxyglucose Positron Emission Tomography and Coronary Computed Tomography in Assessing Vascular Inflammation in Healthy Population.
Cross section study

Heart Disease, Ischemic, or Atherosclerosis, Coronary Clinical Trial using adenosine

Northwestern University - Recruiting 18 years or older.
- Comprehensive Evaluation of Ischemic Heart Disease Using MRI.
adenosine

Chronic Disease, Kidney Diseases, or Cardiovascular Diseases Clinical Trial using rosiglitazone

Hospital Authority, Hong Kong - Recruiting 20 years to 75 years.
- Targeting Peroxisome Proliferator-activated Receptor-gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?.
rosiglitazone

Coronary Artery Disease, Atherosclerosis, Thrombosis, or Acute My Clinical Trial using Drug eluting balloon; Bare metal stent; Drug eluting stent

UMC Utrecht - Recruiting 18 years to 80 years.
- Randomized Comparison of Drug Eluting Balloon/Bare Metal Stent Versus Drug Eluting Stent Versus Bare Metal Stent for the Treatment of Patients With Acute ST-elevation Myocardial Infarction.
Drug eluting balloon; Bare metal stent; Drug eluting stent

Renal Transplantation Clinical Trial using Vascular ultrasound

University of Zurich - Recruiting 18 years or older.
- .
Vascular ultrasound

Prevention, Screening, Abdominal Aortic Aneurysms, Peripheral Art Clinical Trial using Screening for hypertension, lower limb atherosclerosis and abdominal aortic aneurysm

Viborg Hospital - Recruiting 65 years to 74 years.
- Randomized Preventive Vascular Screening Trial of 65-74 Year Old Men in the Central Region of Denmark.
Screening for hypertension, lower limb atherosclerosis and abdominal aortic aneurysm

Metabolic Diseases, Sleep Apnea, or Atherosclerosis Clinical Trial

University Hospital, Angers - Recruiting 18 years to 80 years.
- Impact of Adipose Tissue Repartition on the Time Course of Vascular Dysfunction - the NUMEVOX Cohort.

Atherosclerosis Clinical Trial using Atorvastatin; Aggressive lifestyle intervention

Ministry of Science and Technology of the People's Republic of China - Recruiting 40 years to 70 years.
- Effect of Atorvastatin and Lifestyle Intervention on Progression of Carotid Intima-Media Thickness in Chinese People Without Manifest Atherosclerotic Disease.
Atorvastatin; Aggressive lifestyle intervention

Type 2 Diabetes, or Obesity Clinical Trial using laparoscopic gastric banding

Garvan Institute of Medical Research - Recruiting 18 years to 70 years.
- The Role of Adipocyte-Derived Inflammatory Cytokines in the Pathogenesis of Diabetes, Dyslipidaemia, Atherosclerosis and Gastro-Oesophageal Reflux Disease: the Effects of Medical and Surgical Weight Loss.
laparoscopic gastric banding